MOORESTOWN, N.J., April 13, 2021 /PRNewswire/ -- Tabula
Rasa HealthCare, Inc. ("TRHC") (NASDAQ: TRHC), a leading
healthcare technology company advancing the safe use of medication,
today announced an expansion of COVID-19 services for independent
and chain pharmacies. TRHC's technology-driven patient engagement
solutions will support pharmacists in the administration of and
reporting for the COVID-19 vaccine.
Through TRHC's PrescribeWellness patient-relationship management
solution, community pharmacies can achieve preparedness,
compliance, and expanded patient reach during the critical,
nationwide rollout of the COVID-19 vaccine. Innovative services
such as contact-free vaccination management – a virtual,
patient-friendly vaccination intake and scheduling tool – enable
community pharmacies to engage their patients effectively and
safely for the administration of the COVID-19 vaccine and
beyond.
The federal government's recent introduction of the Federal
Retail Pharmacy Program, a nationwide collaborative to employ
community pharmacists as key vaccine administrators, extends the
commitment of TRHC's PrescribeWellness to continue serving
frontline pharmacy providers through software capabilities that
support timely and compliant reporting to both state and federal
entities.
"With the federal government's endorsement of community
pharmacists as critical providers of the COVID-19 vaccine,
pharmacies now face unprecedented workflow and operational
challenges," says Farah Madhat,
PharmD, MA, executive vice president for TRHC. "With these new
demands, TRHC remains committed to supporting our frontline
pharmacy partners to address these challenges as opportunities for
advancement of the pharmacist within the community."
In addition to software capabilities, TRHC also deploys
telephonic patient engagement services to support pharmacies with
communications necessary for COVID-19 vaccine initiatives.
TRHC's patient-centric tele-pharmacy services are delivered
through TRHC's MedWiseRx™ clinical call centers, a nationwide
network leveraging HIPAA-compliant and HITRUST CSF certified
technology. The services provided by MedWiseRx are designed to
directly support independent and chain pharmacies with COVID-19
vaccine efforts, and to expand vaccine education and accessibility
to patients in need.
MedWiseRx's clinical call centers are staffed by more than 800
pharmacists and pharmacy staff who communicate in more than 30
languages. Telephonic services delivered by TRHC's MedWiseRx range
from vaccine appointment scheduling to addressing and resolving
vaccine hesitancy experienced by patients. TRHC complies with
all HIPAA and HITRUST regulations to ensure the privacy of patient
data and only uses data gathered to facilitate scheduling
appointments.
For more information on TRHC's comprehensive COVID-19 vaccine
solutions and services, please visit us online here: COVID-19
Vaccine Patient Support Services.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare
(NASDAQ: TRHC) provides medication safety solutions that empower
healthcare professionals to optimize medication regimens and reduce
medication-related risk, specifically targeting adverse drug
events. TRHC's technology solutions, including DoseMeRx™ and
MedWise®, improve patient outcomes, reduce hospitalizations, and
lower healthcare costs. TRHC's extensive clinical tele-pharmacy
network improves care for patients nationwide. Its solutions are
trusted by health plans and pharmacies to help drive value-based
payment results. For more information, visit TRHC.com.
Forward-Looking Statements
This press release includes forward-looking statements that we
believe to be reasonable as of today's date, including statements
regarding Medication Risk Mitigation technology. Such statements
are identified by use of the words "anticipates," "believes,"
"estimates," "expects," "intends," "plans," "predicts," "projects,"
"should," and similar expressions. These forward-looking statements
are based on management's expectations and assumptions as of the
date of this press release. Actual results might differ materially
from those explicit or implicit in the forward-looking statements.
Important factors that could cause actual results to differ
materially include: the need to innovate and provide useful
products and services; risks related to changing healthcare and
other applicable regulations; increasing consolidation in the
healthcare industry; managing our growth effectively; our ability
to adequately protect our intellectual property; and the other risk
factors set forth from time to time in our filings with the SEC,
including those factors discussed under the caption "Risk Factors"
in our most recent annual report on Form 10-K, filed with the SEC
on February 26, 2021, and in
subsequent reports filed with or furnished to the SEC, copies of
which are available free of charge within the Investor Relations
section of the TRHC website ir.trhc.com or upon request from our
Investor Relations Department. Any forward-looking statement speaks
only as of the date on which it was made. TRHC assumes no
obligation and does not intend to update these forward-looking
statements, except as required by law, to reflect events or
circumstances occurring after today's date.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/tabula-rasa-healthcare-expands-covid-19-vaccine-support-services-to-community-pharmacies-301267227.html
SOURCE Tabula Rasa HealthCare, Inc.